1 study on Cyclin d3 cdk4 cdk6 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**GHS-R1a agonists may represent a single-class intervention capable of addressing GH decline, metabolic liver aging, immune senescence, and dopaminergic deficits simultaneously** — a breadth no current approved thera…